Image Image Image Image Image Image Image Image Image

Gary Bellaver, Licensing | incuba8

30 Jul


Gary Bellaver, Dow Technology & Licensing

July 30, 2009 | By |

Gary Bellaver received a Bachelor of Science degree in Chemical Engineering from Michigan State University in 1986, and has worked for the Dow Chemical Company in Midland, Michigan for 23 years.  His career started in day-to-day commercial scale manufacturing in Dow Pharmaceuticals, participating and leading production processes responsible for the active ingredients for some of the largest volume prescription drugs in history.  Over the course of 20 years spent in Dow Pharmaceuticals, his key job responsibilities evolved from production engineering, capital project management, leading scale up of developmental processes to full commercial scale, financial analysis and value proposition creation of new opportunities, to negotiations with new customers interested in Dow’s pharmaceutical manufacturing offerings.  Over the course of this time, he has accumulated a broad understanding of industrial chemical engineering, project and program management, financial and business analysis, and FDA / EPA regulatory principles.

In 2006, Gary transitioned into Dow’s Technology and Licensing business, and currently holds the title of Senior Leader, Dow Technology & Licensing.  In this role, he is responsible for Dow’s methodology for valuation of the Corporation’s Intellectual Property, valuation of specific licensing inquiries and projects, and constructing, presenting, and negotiating value propositions and license contracts with external clients.

Gary Bellaver spoke at the Aug ‘09 Incuba8 Business Setup Conference . Register Now!

Presentation: Out Licensing Your Technology

Description: This presentation will focus on the critical aspects of licensing as it pertains to a business. Basic concepts such as types of licenses, important terms and conditions, resources for creating and sustaining a license business, and valuation of licensed intellectual property will be discussed.